Skip to main content
OpenTrials

Clinical trial condition

Metastatic Hepatocellular Carcinoma

Explore clinical trials studying Metastatic Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.

26 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Hepatocellular Carcinoma trial results

Recruiting

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

NCT07227012

Conditions
Adenocarcinoma, Advanced Hepatocellular Carcinoma, Carcinoma, +13 more
Locations
  • Keck Hospital of USC Los Angeles, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC/Norris Comprehensive Cancer Center / Investigational Drug Services Los Angeles, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 54 locations
View Trial Details
Recruiting

Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer

NCT05168163

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +17 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Cleveland Clinic Weston Florida Weston, Florida, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
View all 16 locations
View Trial Details
Recruiting

Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial

NCT06811116

Conditions
Adenocarcinoma, Advanced Hepatocellular Carcinoma, Carcinoma, +12 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details
Recruiting

A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

NCT06427941

Conditions
Adenocarcinoma, Alpha-fetoprotein (AFP)-Producing Gastric Cancer, Carcinoma, +14 more
Locations
  • City of Hope Phoenix Cancer Center Goodyear, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope Chicago Cancer Center Zion, Illinois, United States
  • Memorial Sloan Kettering Cancer Center Mskcc New York, United States
View all 47 locations
View Trial Details
Recruiting

A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

NCT06600321

Conditions
Adenocarcinoma, Advanced Hepatocellular Carcinoma, Carcinoma, +10 more
Locations
  • Clinical Trial Site Phoenix, Arizona, United States
  • Clinical Trial Site La Jolla, California, United States
  • Clinical Trial Site Los Angeles, California, United States
  • Clinical Trial Site Jacksonville, Florida, United States
View all 23 locations
View Trial Details

Related conditions